Shulman Joseph's Form 4/A amendment
AmendedRhythm Pharmaceuticals, Inc. (RYTM) · filed Feb 14, 2023
- Accession no.
- 0001104659-23-022067
- Filed
- Feb 14, 2023
- Trade date
- Feb 9, 2023
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Feb 13, 2023
This filing lists 1 non-derivative transaction. It carries over 2 transactions from the original filing that it did not restate. Open-market sales total $25.6K. It was filed 5 days after the trade.
This amendment restates part of 0001104659-23-019810 (filed Feb 13, 2023). The transactions it did not restate still count and are listed below.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Shulman JosephCIK 0001909855 | Officer (Chief Technical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 9, 2023 | Common Stock | SSaleDisposed | −931 | $27.51 | −$25,611.81 | 2,732 | Direct |
Carried over from the original filing
This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.
From 0001104659-23-019810 (filed Feb 13, 2023).
Non-derivative securities (Table I)
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 9, 2023 | Common Stock | MOption exerciseAcquired | +2,657 | –F1 | – | 3,663 | Direct |
Derivative securities (Table II)
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 9, 2023 | Common Stock | MOption exerciseDisposed | −2,657 | $0.00 | $0 | 7,968 | Direct |
Footnotes on the original
The footnotes that the prices of these transactions refer to on the original filing.
- F1
Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
Referenced by the price of 1 transaction in Table I.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units.
Remarks
This amended Form 4 is being filed solely for the purpose of correcting an administrative error in the number of shares sold and sale price which were initially reported on the Form 4 filed on February 13, 2023.